ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "American College of Rheumatology Criteria"

  • Abstract Number: 0005 • ACR Convergence 2020

    Geographical Variations in COVID-19 Perceptions and Patient Management: A National Survey of Rheumatologists

    Bella Mehta1, Deanna Jannat-Khah2, Carol Mancuso3, Anne Bass1, Carine Moezinia4, Allan Gibofsky3, Susan Goodman5 and Said Ibrahim6, 1Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York City, NY, 3Hospital for Special Surgery, New York City, 4Hospital for Special Surgery, New York, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 6Weill Cornell Medicine, Cleveland, OH

    Background/Purpose: To investigate the perceptions and behaviors of rheumatologists in the United States (US) regarding the risk of COVID-19 for their autoimmune patients and the…
  • Abstract Number: 0351 • ACR Convergence 2020

    Ustekinumab-Treated Patients with Psoriatic Arthritis in a Real-world Study: Similar Clinical Responses and Treatment Persistence over One Year in Elderly and Younger Patients

    Laure Gossec1, Elke Theander2, Soumya Chakravarty3, Paul Bergmans4, Iris Lin5, Wim Noël6, Stefan Siebert7 and Josef Smolen8, 1Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, 2Janssen Cilag, Lund, Sweden, 3Janssen Scientific Affairs, LLC, Horsham, PA, USA and Drexel University College of Medicine, Horsham, PA, 4Janssen Biostatistics and Medical Affairs, Tilburg, Netherlands, 5Janssen Immunology Global Commercial Strategy Organization, Horsham, 6Janssen Medical Affairs, LLC, Beerse, Belgium, 7University of Glasgow, Glasgow, United Kingdom, 8Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria

    Background/Purpose: In the PsABio study (NCT02627768), real-world data from patients with PsA showed comparable clinical results after treatment with ustekinumab (UST, an anti-p40 IL-12/23 inhibitor)…
  • Abstract Number: 0359 • ACR Convergence 2020

    Clinical Characteristics of Psoriatic Arthritis Patients with Physician-Identified Spondylitis, According to HLA-B27 Status: An Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

    Philip Mease1, Soumya Chakravarty2, Robert McLean3, Taylor Blachley3, Toana Kawashima4, Iris Lin5, Jonathan Uy6, Arthur Kavanaugh7 and Alexis Ogdie8, 1Seattle Rheumatology Associates, P.L.L.C., Seattle, WA, 2Janssen Scientific Affairs, LLC, Horsham, PA, USA and Drexel University College of Medicine, Horsham, PA, 3Corrona, LLC, Waltham, MA, 4Corrona, LLC, Waltham, 5Janssen Immunology Global Commercial Strategy Organization, Horsham, 6Janssen Scientific Affairs, LLC, Horsham, 7UC San Diego Health System, San Diego, CA, 8Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Axial disease in psoriatic arthritis (PsA) has been reported to occur in anywhere from 25% to 75% of PsA patients (pts). It can be…
  • Abstract Number: 0414 • ACR Convergence 2020

    Clinical Characteristics of an Internet-Based Cohort of Participants with a Self-Reported Diagnosis of Cryoglobulinemic Vasculitis or IgA Vasculitis

    Jason Springer1, Tanaz Kermani2, Dianne Shaw3, Kalen Young4, Cristina Burroughs5 and Peter Merkel6, 1University of Kansas Medical Center, Overland Park, KS, 2David Geffen School of Medicine / University of California, Los Angeles, CA, 3Vasculitis Foundation, North Carolina, 4Vasculitis Foundation, Kansas City, 5University of South Florida, Tampa, 6University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Cyroglobulinemic vasculitis (CV) and IgA vasculitis are forms of small-vessel vasculitis characterized by immune complex deposition. The purpose of this study was to a)…
  • Abstract Number: 0416 • ACR Convergence 2020

    IgG4-related Retroperitoneal Fibrosis. Retrospective Cohort

    Ernestina Angarola1, Federico Jauk2, Verónica Peuchot3, Maria Orlova1, Melina Valeo2, Javier Pollan1 and Hernán Garcia Rivello2, 1Department of Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 2Department of Pathology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 3Internal Medicine Research Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina

    Background/Purpose: The spectrum of IgG4-related disease (IgG4-RD) includes many diseases that were thought to be confined to a single organ, as the retroperitoneal fibrosis. Many…
  • Abstract Number: 0676 • ACR Convergence 2020

    Surveying Practicing Rheumatologists Regarding Gout Management and Barriers in Gout Care

    Joshua Gavin1, Yashswee KC2, Evan Dombrosky3, Nehal Shah4 and Youssef Roman4, 1Virginia Commonwealth University School of Medicine, Richmond, 2Virginia Commonwealth University School of Medicine, Henrico, VA, 3Virginia Commonwealth University School of Medicine, Glen Allen, VA, 4Virginia Commonwealth University School of Medicine, Richmond, VA

    Background/Purpose: The management of gout is heterogeneous across specialties and clinical settings. Gout has been demonstrated to be one of the most poorly managed conditions…
  • Abstract Number: 0717 • ACR Convergence 2020

    Predictors of Clinical Remission in Children with Extended Oligoarticular Arthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis Treated with Etanercept in the CLIPPER Studies

    Jelena Vojinovic1, Vyacheslav Chasnyk1, Joke Dehoorne1, Violeta Panaviene1, Jonathan Akikusa2, Tadej Avcin1, Jeffrey Chaitow1, Bernard Lauwerys1, Jordi Antón1, Inmaculada Penades1, Berit Flato1, Alina Boteanu3, Hans-Iko Huppertz1, Juan Jaller1, Daniela Graham4, Cecilia Borlenghi5, Bonnie Vlahos6, Chuanbo Zang6 and Nicolino Ruperto2, 1Paediatric Rheumatology International Trials Organisation (PRINTO), Genoa, Italy, 2PRINTO, Istituto Giannina Gaslini, Genova, Italy, 3Hospital Universitario Ramón y Cajal, Madrid, Spain, 4Pfizer, Groton, PA, 5Pfizer, New York, NY, 6Pfizer, Collegeville, PA

    Background/Purpose: CLIPPER is an ongoing, 8-year, phase 3b, multicenter, open-label study of the safety and efficacy of etanercept in the treatment of juvenile idiopathic arthritis…
  • Abstract Number: 1080 • ACR Convergence 2020

    Sensitivity and Specificity of the 2017 EULAR/ACR Criteria for Idiopathic Inflammatory Myopathies in a Cohort of Patients from Latin America

    Antonia Maria Valenzuela Vergara1, Magdalena Torres1 and Alejandro Deves1, 1Pontificia Universidad Catolica de Chile, Santiago de Chile, Chile

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of diseases characterized by muscle inflammation and internal organ involvement. The Bohan & Peter (B&P) criteria…
  • Abstract Number: 1511 • ACR Convergence 2020

    Clinical Features and Select Dysregulated Immune Parameters Distinguish Blood Relatives Who Remain Clinically Stable or Progress to Incomplete Lupus or Classified SLE in the Lupus Autoimmunity in Relatives (LAUREL) Follow-up Cohort

    Melissa Munroe1, Kendra Young2, Jill Norris3, Joel Guthridge4, Diane Kamen5, Timothy Niewold6, Gary Gilkeson7, Michael Weisman8, Mariko Ishimori9, Daniel Wallace10, David Karp11, John Harley12 and Judith James13, 1Oklahoma Medical Research Foundation/Progentec Diagnostics, Inc., Oklahoma City, OK, 2University of Colorado Denver, Aurora, CO, 3Colorado School of Public Health, Aurora, CO, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Medical University of South Carolina, Charleston, SC, 6NYU School of Medicine, New York, NY, 7Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 8Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA, LOS ANGELES, CA, 9Cedars-Sinai Medical Center, Los Angeles, CA, 10Cedars-Sinai Medical Center/UCLA, Los Angeles, CA, 11UT Southwestern Medical Center, Dallas, TX, 12Cincinnati Children's Hospital Medical Center/Univ of Cincinnati College of Medicine, Cincinnati, OH, 13Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation;Department of Pathology, University of Oklahoma Health Sciences Center;Department of Medicine, University of Oklahoma Health Sciences Center, Edmond, OK

    Background/Purpose: Identifying populations at risk of SLE is essential to curtail inflammatory damage and identify individuals for prevention trials. Unaffected blood relatives (BRs) of lupus…
  • Abstract Number: 1609 • ACR Convergence 2020

    The Accuracy of Administrative Health Data for Identifying Patients with Rheumatoid Arthritis: A Validation Study Using Medical Records in Western Australia

    Khalid Almutairi1, Johannes Nossent1, David Preen1, Helen Keen1, Katrina Rogers2 and Charles Inderjeeth1, 1The University of Western Australia, Perth, Western Australia, Australia, 2Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

    Background/Purpose: The use of large administrative health datasets is increasingly important in Rheumatology for disease trends and outcome research. We established the West Australian Rheumatic…
  • Abstract Number: PP01 • ACR Convergence 2020

    Impacting Change Through Facilitation and Advocacy for Lupus

    Monica Watson1, 1Lupus Foundation of America, Darby, PA

    Background/Purpose: My story started as one of disbelief in 2009 with my Lupus diagnosis. How could a woman in the prime of her career be…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.